2019 World Molecular Imaging Conference Poster

This study is the Company's first reported results demonstrating that the anti-HER2 nanoparticles used in Imagion's Magsense™ technology, which provide…


MR Imaging Market Coming Into Focus

In our September newsletter we announced that researchers at the University of Sydney had received an industry collaboration grant to investigate the use of…


What's New in Medical Imaging — Radio Interview with Mike Harsh

Click play icon ▶️ to listen (transcript follows below):…


MagSense Technology Animation

. Cancer treatments are most effective, and patient outcomes are improved, when tumors are detected early. Imagion Biosystems is developing the MagSense®…


MagSense Technology Leading a Broad Trend in Cancer Medicine

This article represents the viewpoint of management. MagSense® technology is taking a leading position amidst a broad trend in cancer medicine toward finding…


Investor Update — Corporate Presentation Visuals

Imagion Biosystems has updated investors by lodging the latest version of its corporate presentation visuals with the Australian Securities Exchange. Content…


Introduction to Magnetic Relaxometry

This video (below) captures the opening minutes of CEO Bob Proulx's address to the 2016 NobleCon meeting, where he outlines the medical need for a new cancer…


Appendix 4C for Q2 2017

In accord with ASX requirements, Imagion Biosystems' quarterly financial statement Appendix 4C was lodged with the Australian Securities Exchange on 31 July,…